Market Movers
Pre-Market and After Hours Market Movers
-
Stock Market Today: Stocks Dip as Israel’s Iran Attack Drives Oil Prices Higher
U.S. stocks had a significant pullback on Friday, with markets shaken by Israel’s airstrike on Iran, which has escalated tensions…
Read More » -
Arista Networks’ Stunning Reversal: From Avoided To Adored — Why Wall Street Sees Strong Upside Ahead!
Over the past year, Arista Networks has staged one of the most impressive comebacks on Wall Street, transforming from a…
Read More » -
Bitcoin’s Bullish Momentum: Companies Embrace the Token as Inflation Hedge
Bitcoin (BTC-USD) has been surging in value as companies have increasingly begun to integrate the cryptocurrency into their balance sheets,…
Read More » -
Stock Market Today: Inflation Data Fuels Hopes for Rate Cuts
U.S. stocks were mixed on Wednesday as investors reacted to a softer-than-expected inflation reading and evaluated a potential U.S.-China trade…
Read More » -
Viking Holdings Could Be the Next Top Performing Cruise Stock — Is It A Buying Opportunity?
Viking Holdings, known for its luxury river and ocean cruises, recently rattled some investors despite posting strong first-quarter results yet…
Read More » -
Circle’s IPO Triggers ETF Surge as Crypto Enters Mainstream Investment Landscape
Circle Internet Group, the issuer of USDC (the second-largest stablecoin), has fueled a frenzied interest on Wall Street following its…
Read More » -
Stock Market Today: Stocks Hold Steady as Investors Wait on US-China Trade Talks
Today, the U.S. stock market had a mixed performance while investors stay cautious during ongoing U.S.-China trade talks.
Read More » -
Snowflake Just Got Crunchy: The $250M Bet That Could Change the AI Data Game!
In a bold step to strengthen its AI-focused data platform ambitions, Snowflake has announced the acquisition of Crunchy Data, a…
Read More » -
Bristol Myers’ $11.1 Billion Bet on BioNTech: Is Oncology The New Growth Engine?
Bristol Myers has inked a transformative partnership for BNT327, a bispecific PD-L1/VEGF-A antibody developed by BioNTech, with a $1.5 billion…
Read More » -
Bitcoin’s Rally Drives Profits for Strategy, Boosting Investor Confidence
Bitcoin’s recent rally has become a major catalyst for companies like Strategy (MSTR), which has seen its cryptocurrency holdings become…
Read More »
